False-positive somatostatin receptor scintigraphy due to an accessory spleen

Journal of Nuclear Medicine

Volumn 38, Issue 12, 1997, Pages 1979-1981

  Lebtahi, R ^a   Cadiot, G ^b   Marmuse, J P ^b   Vissuzaine, C ^b   Petegnief, Y ^b   Courillon Mallet, A ^b   Cattan, D ^b   Mignon, M ^b   Le Guludec, D ^b  

^a BICHAT HOSPITAL   (France)

^b NONE

Author keywords

Accessory spleen; Gastroenteropancreatic tumors; Somatostatin receptor scintigraphy

Indexed keywords

PENTETREOTIDE IN 111; SOMATOSTATIN; SOMATOSTATIN RECEPTOR;

ACCESSORY SPLEEN; ADULT; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; ENDOSCOPIC ECHOGRAPHY; HUMAN; LAPAROTOMY; MALE; PANCREAS RESECTION; PRIORITY JOURNAL; SCINTIGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPLENECTOMY; ZOLLINGER ELLISON SYNDROME;

FALSE POSITIVE REACTIONS; HUMANS; INDIUM RADIOISOTOPES; MALE; MIDDLE AGED; RECEPTORS, SOMATOSTATIN; SOMATOSTATIN; SPLEEN; ZOLLINGER-ELLISON SYNDROME;

EID: 0031446912     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. 123I-Thyr3-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med 1993;20:716-731.
2. 111In-pentetreotide for endocrine gastroenteropancreatic rumors. Horm Metab Res 1993;27(suppl):28-35.
3. De Kerviler E, Cadiot G, Lebtahi R, et al. Somatostatin receptor scintigraphy in forty-eight patients with the Zollinger-Ellison syndrome. Eur J Nucl Med 1994;21: 1191-1197.
4. 111In-pentetreotide scintigraphy. Semin Oncol 1994;21:15-20.
5. 111-pentreotide in gastroenteropancreatic neuroendocrine tumors: safety, efficacy and impact on patient management. J Nucl Med 1995;36:542-549.
6. Lebtahi R, Cadiot G, Sarda L, et al. Clinical impact of somatostatin receptor scintigraphy in the management of patients with neuroendocrine gastroenteropancreatic tumors. J Nucl Med 1997;38:853-858.
7. Gibril F, Reynolds JC, Dopmann JL, et al. Somatostatin receptor scintigraphy: its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinoma. Ann Intern Med 1996;125:26-34.
8. Cadiot G, Lebtahi R, Sarda L, et al. Preoperative detection of duodenal gastrinomas and peripancreatic lymph nodes by somatostatin receptor scintigraphy. Gastroenterology 1996;111:845-854.
9. Cadiot G, Bonnaud G, Lebtahi R. Somatostatin-receptor scintigraphy findings susceptible to modify management of patients with the Zollinger-Ellison syndrome. Gut 1997;41:107-114.
10. Mignon M, Jais P, Cadiot G, Ben Yedder D, Vatier J. Clinical features and advances in biological diagnostic criteria for Zollinger-Ellison Syndrome. In: Mignon M, Jensen RT, eds. Endocrine tumors of the pancreas: recent advances. Basel, Switzerland: Karger Basel Publishers; 1995:309-332.
11. Norton JA, Doppman JL, Jensen RT. Curative resection in Zollinger Ellison syndrome: results of a 10-years prospective study. Ann Surg 1992;215:8-18.
12. Fraker DL, Norton JA, Alexander HR, Venzon DJ, Jensen RT. Surgery in Zollinger Ellison syndrome alters the natural history of gastrinoma. Ann Surg 1994;220:320-330.
13. Hayward I, Mindelzun RE, Jeffrey RB. Intrapancreatic accessory spleen mimiking pancreatic mass on CT. J Comput Assist Tomogr 1992;16:985-986.
14. Vuong PN, Vaury P, Galet B, Baviera E. Accessory spleen in the left ovary. Discussion on its pathogenesis. J Gynecol Obstet Biol Reprod 1989;18:753-755.
15. Miller EJ, Nowak E, Hair L, Mouradian J. Retroperitoneal accessory spleen. Am Surg 1990;56:293-294.
16. Reubi JC, Kvols L, Krenning EP, Lamberts SWJ. Distribution of somatostatin receptor in normal and tumour tissue. Metabolism 1990;30(suppl 2):78-81.
17. Reubi JC, Kvols L, Krenning EP, Lamberts SWJ. In vivo in vitro detection of somatostatin receptor scintigraphy in human malignant tissues. Acta Oncologica 1991;30:463-468.
18. Krenning EP, Kwekkeboom DJ, de Jong M, et al. Essential of peptide receptor scintigraphy with emphasis on the somatostatin analog octreotide. Semin Oncol 1994;21:13:6-14.
19. Lamberts SWJ, Reubi JC, Krenning EP. Somatostatin and the concept of peptide receptor scintigraphy in oncology. Semin Oncol 1994;21:13:1-5.
20. Levin TL, Berdon WE, Haller JO, Ruzal-Shapiro C, Hurlet-Jenson A. Intrasplenic masses of preserved functioning splenic tissue in sickle cell disease: correlation of imaging findings (CT, ultrasound, MRI, nuclear scintigraphy). Pediatr Radiol 1996; 26:646-649.